Prime Medicine has about $61.2 million in cash and short-term investments as of September 30, 2026.

Nov 10, 2026, 4:09 PM ETResultsRead the original at SEC EDGAR

Neutral

Prime Medicine reported a preliminary cash estimate, but gave no earlier figure or spending rate to show what it means for available time. The estimate is unfinished, so it does not establish a change in the company's outlook.

PRME · Prime Medicine, Inc.

AI read · Neutral

The AI's read

The cash estimate gives no comparison with an earlier quarter or estimate of how quickly the company spends cash. The company said outside accountants have not checked the estimate, and it may change when the quarter-end work is complete. The filing also mentions an updated presentation but gives no new business results in its text.

Get alerts for PRME

Follow Prime Medicine, Inc. (PRME) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PRME

Free on the App Store and Google Play, or on the web.